China launched the research and development project of early diagnosis and treatment of malignant tumor screening

, Beijing, August 30 (Xinhua Tian Xiaohang) known as the "life and health of the first killer" of cancer is an unpleasant change of color, but if you can find this "killer" early, it will be difficult to "kill." The project "Research and evaluation of liquid biopsy technology for early diagnosis of malignant tumor screening" included in the national key research and development plan was launched in Beijing recently to help the key technology breakthrough of early screening of multiple cancers.
" early screening is the most effective way to reduce the death of malignant tumors. Professor Wang Jie, project leader and director of internal medicine at China Medical
Oncology Hospital, said that high-volume liquid biopsies are a breakthrough in the early diagnosis of cancer, but the current research of this technology is faced with bottlenecks such as insufficient test sensitivity and lack of highly specific molecular targets for liquid biopsies.
Reporters at the launch ceremony of the project learned that the project for the national key research and development program "major chronic noncommunicable diseases prevention and control research" key special support projects, the goal is to focus on breaking through the malignant tumor screening early diagnosis and treatment of liquid biopsy key technology, the construction of high sensitivity, high specificity, high efficiency and economy of malignant tumor liquid biopsy early diagnosis technology system, the development of fully independent intellectual property rights screening / early diagnosis kit, and for lung cancer and digestive system cancer in large-scale multi-center forward-looking queue.
Liu Wei, deputy director of colorectal surgery at
China Medical Hospital, believes that by taking extraterrescret blood to detect free DNA released into the blood by tumor cells, the detection rate of early cancer and precancerote lesions can be improved. "As technology continues to evolve and evolve, it is entirely possible for this approach to achieve sensitivity and specificity similar to invasive inspections, while being easy to operate, non-invasive, and standardized in its processes."
"China's malignant tumor patients to the hospital often late. At the
launch ceremony of the project, He Jie, director of the National Cancer Center of China, said that research on cancer screening and early diagnosis and treatment should be more in-depth, widespread and practical for the benefit of patients.